Global Gastric Cancer Drugs Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2024

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 90
This report studies the global Gastric Cancer Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Gastric Cancer Drugs market by companies, region, type and end-use industry.

Gastric cancer drugs are used to treat malignancies, or cancerous growths.
The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive market share of nearly 45% during the forecast period.
The world gastric cancer drugs market could be classified into seven types: doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab.
In 2017, the global Gastric Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global top players, covered
    Sanofi
    Eli Lilly
    F. Hoffmann-La Roche
    Otsuka Pharmaceutical
    Novartis
    Amgen
    Merck
    AstraZeneca
    Boehringer Ingelheim
    Daiichi-Sankyo
    Bayer HealthCare

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

Market segment by Type, the product can be split into
    Doxorubicin Hydrochloride
    Sunitinib
    Docetaxel
    Mitomycin
    Fluorouracil
    Imatinib
    Trastuzumab

Market segment by Application, split into
    Hospitals
    Clinics
    Other

The study objectives of this report are:
    To study and forecast the market size of Gastric Cancer Drugs in global market.
    To analyze the global key players, SWOT analysis, value and global market share for top players.
    To define, describe and forecast the market by type, end use and region.
    To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
    To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Gastric Cancer Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Gastric Cancer Drugs Manufacturers
Gastric Cancer Drugs Distributors/Traders/Wholesalers
Gastric Cancer Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Gastric Cancer Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Global Gastric Cancer Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Gastric Cancer Drugs
    1.1  Gastric Cancer Drugs Market Overview
        1.1.1 Gastric Cancer Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Gastric Cancer Drugs Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 Europe
        1.2.3 China
        1.2.4 Japan
        1.2.5 Southeast Asia
        1.2.6 India
    1.3 Gastric Cancer Drugs Market by Type
        1.3.1 Doxorubicin Hydrochloride
        1.3.2 Sunitinib
        1.3.3 Docetaxel
        1.3.4 Mitomycin
        1.3.5 Fluorouracil
        1.3.6 Imatinib
        1.3.7 Trastuzumab
    1.4 Gastric Cancer Drugs Market by End Users/Application
        1.4.1 Hospitals
        1.4.2 Clinics
        1.4.3 Other

2 Global Gastric Cancer Drugs Competition Analysis by Players
    2.1 Gastric Cancer Drugs Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Sanofi
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.2 Eli Lilly
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.3 F. Hoffmann-La Roche
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.4 Otsuka Pharmaceutical
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.5 Novartis
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.6 Amgen
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.7 Merck
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.8 AstraZeneca
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.9 Boehringer Ingelheim
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.10 Daiichi-Sankyo
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Gastric Cancer Drugs Revenue (Million USD) (2013-2018)
    3.11 Bayer HealthCare

4 Global Gastric Cancer Drugs Market Size by Type and Application (2013-2018)
    4.1 Global Gastric Cancer Drugs Market Size by Type (2013-2018)
    4.2 Global Gastric Cancer Drugs Market Size by Application (2013-2018)
    4.3 Potential Application of Gastric Cancer Drugs in Future
    4.4 Top Consumer/End Users of Gastric Cancer Drugs

5 United States Gastric Cancer Drugs Development Status and Outlook
    5.1 United States Gastric Cancer Drugs Market Size (2013-2018)
    5.2 United States Gastric Cancer Drugs Market Size and Market Share by Players (2013-2018)
    5.3 United States Gastric Cancer Drugs Market Size by Application (2013-2018)

6 Europe Gastric Cancer Drugs Development Status and Outlook
    6.1 Europe Gastric Cancer Drugs Market Size (2013-2018)
    6.2 Europe Gastric Cancer Drugs Market Size and Market Share by Players (2013-2018)
    6.3 Europe Gastric Cancer Drugs Market Size by Application (2013-2018)

7 China Gastric Cancer Drugs Development Status and Outlook
    7.1 China Gastric Cancer Drugs Market Size (2013-2018)
    7.2 China Gastric Cancer Drugs Market Size and Market Share by Players (2013-2018)
    7.3 China Gastric Cancer Drugs Market Size by Application (2013-2018)

8 Japan Gastric Cancer Drugs Development Status and Outlook
    8.1 Japan Gastric Cancer Drugs Market Size (2013-2018)
    8.2 Japan Gastric Cancer Drugs Market Size and Market Share by Players (2013-2018)
    8.3 Japan Gastric Cancer Drugs Market Size by Application (2013-2018)

9 Southeast Asia Gastric Cancer Drugs Development Status and Outlook
    9.1 Southeast Asia Gastric Cancer Drugs Market Size (2013-2018)
    9.2 Southeast Asia Gastric Cancer Drugs Market Size and Market Share by Players (2013-2018)
    9.3 Southeast Asia Gastric Cancer Drugs Market Size by Application (2013-2018)

10 India Gastric Cancer Drugs Development Status and Outlook
    10.1 India Gastric Cancer Drugs Market Size (2013-2018)
    10.2 India Gastric Cancer Drugs Market Size and Market Share by Players (2013-2018)
    10.3 India Gastric Cancer Drugs Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Gastric Cancer Drugs Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Gastric Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.2 Europe Gastric Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.3 China Gastric Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.4 Japan Gastric Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.5 Southeast Asia Gastric Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.6 India Gastric Cancer Drugs Revenue and Growth Rate (2018-2025)
    11.2 Global Gastric Cancer Drugs Market Size (Value) by Type (2018-2025)
    11.3 Global Gastric Cancer Drugs Market Size by Application (2018-2025)

12 Gastric Cancer Drugs Market Dynamics
    12.1 Gastric Cancer Drugs Market Opportunities
    12.2 Gastric Cancer Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Gastric Cancer Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Gastric Cancer Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source



List of Tables and Figures

    Figure Global Gastric Cancer Drugs Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Gastric Cancer Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Gastric Cancer Drugs Market Share by Regions (2013-2018)
    Figure United States Gastric Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Europe Gastric Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Gastric Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Gastric Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Gastric Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Gastric Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Gastric Cancer Drugs Revenue Market Share by Type in 2017
    Figure Doxorubicin Hydrochloride Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Sunitinib Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Docetaxel Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Mitomycin Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Fluorouracil Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Imatinib Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Trastuzumab Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Gastric Cancer Drugs Market Share by Application in 2017
    Figure Gastric Cancer Drugs Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
    Figure Gastric Cancer Drugs Market Size (Million USD) and Growth Rate in Clinics (2013-2018)
    Figure Gastric Cancer Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
    Table Gastric Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure Gastric Cancer Drugs Market Size Share by Players in 2013
    Figure Gastric Cancer Drugs Market Size Share by Players in 2017
    Table Sanofi Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Sanofi (2013-2018)
    Figure Sanofi Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Eli Lilly Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Eli Lilly (2013-2018)
    Figure Eli Lilly Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table F. Hoffmann-La Roche Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
    Figure F. Hoffmann-La Roche Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Otsuka Pharmaceutical Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Otsuka Pharmaceutical (2013-2018)
    Figure Otsuka Pharmaceutical Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Novartis Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Novartis (2013-2018)
    Figure Novartis Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Amgen Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Amgen (2013-2018)
    Figure Amgen Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Merck Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Merck (2013-2018)
    Figure Merck Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table AstraZeneca Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of AstraZeneca (2013-2018)
    Figure AstraZeneca Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Boehringer Ingelheim Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2013-2018)
    Figure Boehringer Ingelheim Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Daiichi-Sankyo Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Daiichi-Sankyo (2013-2018)
    Figure Daiichi-Sankyo Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Bayer HealthCare Basic Information List
    Table Gastric Cancer Drugs Business Revenue (Million USD) of Bayer HealthCare (2013-2018)
    Figure Bayer HealthCare Gastric Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Global Gastric Cancer Drugs Market Size (Million USD) by Product (2013-2018)
    Figure Global Gastric Cancer Drugs Revenue Market Share (%) by Product (2013-2018)
    Figure Global Gastric Cancer Drugs Market Share by Product in 2017
    Table Global Gastric Cancer Drugs Market Size by Application (2013-2018)
    Figure Global Gastric Cancer Drugs Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Gastric Cancer Drugs
    Figure United States Gastric Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Gastric Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure United States Gastric Cancer Drugs Market Size Share by Players in 2013
    Figure United States Gastric Cancer Drugs Market Size Share by Players in 2017
    Table United States Gastric Cancer Drugs Market Size by Application (2013-2018)
    Figure United States Gastric Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure United States Gastric Cancer Drugs Market Size Share by Application in 2017
    Figure Europe Gastric Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table Europe Gastric Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure Europe Gastric Cancer Drugs Market Size Share by Players in 2013
    Figure Europe Gastric Cancer Drugs Market Size Share by Players in 2017
    Table Europe Gastric Cancer Drugs Market Size by Application (2013-2018)
    Figure Europe Gastric Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure Europe Gastric Cancer Drugs Market Size Share by Application in 2017
    Figure China Gastric Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Gastric Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure China Gastric Cancer Drugs Market Size Share by Players in 2013
    Figure China Gastric Cancer Drugs Market Size Share by Players in 2017
    Table China Gastric Cancer Drugs Market Size by Application (2013-2018)
    Figure China Gastric Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure China Gastric Cancer Drugs Market Size Share by Application in 2017
    Figure Japan Gastric Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Gastric Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure Japan Gastric Cancer Drugs Market Size Share by Players in 2013
    Figure Japan Gastric Cancer Drugs Market Size Share by Players in 2017
    Table Japan Gastric Cancer Drugs Market Size by Application (2013-2018)
    Figure Japan Gastric Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Gastric Cancer Drugs Market Size Share by Application in 2017
    Figure Southeast Asia Gastric Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Gastric Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Gastric Cancer Drugs Market Size Share by Players in 2013
    Figure Southeast Asia Gastric Cancer Drugs Market Size Share by Players in 2017
    Table Southeast Asia Gastric Cancer Drugs Market Size by Application (2013-2018)
    Figure Southeast Asia Gastric Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Gastric Cancer Drugs Market Size Share by Application in 2017
    Figure India Gastric Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Gastric Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure India Gastric Cancer Drugs Market Size Share by Players in 2013
    Figure India Gastric Cancer Drugs Market Size Share by Players in 2017
    Table India Gastric Cancer Drugs Market Size by Application (2013-2018)
    Figure India Gastric Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure India Gastric Cancer Drugs Market Size Share by Application in 2017
    Figure Global Gastric Cancer Drugs Market Size and Growth Rate (2018-2025)
    Table Global Gastric Cancer Drugs Market Size (Million USD) by Regions (2018-2025)
    Figure Global Gastric Cancer Drugs Market Size Share (2018-2025)
    Figure Global Gastric Cancer Drugs Market Size Share by Regions in 2025
    Figure United States Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Europe Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Gastric Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Gastric Cancer Drugs Market Size (Million USD) by Type (2018-2025)
    Figure Global Gastric Cancer Drugs Market Size Share by Type in 2018
    Figure Global Gastric Cancer Drugs Market Size Share by Type in 2025
    Table Global Gastric Cancer Drugs Market Size (Million USD) by Application (2018-2025)
    Figure Global Gastric Cancer Drugs Market Size (Million USD) by Application in 2018

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...